October 09, 2024
Boehringer Ingelheim collaborates with Circle Pharma
September 09, 2024
Zongertinib shows encouraging efficacy and tolerability profile in lung cancer patients
August 27, 2024
Boehringer Ingelheim to unveil groundbreaking oncology research at WCLC
July 29, 2024
Boehringer Ingelheim acquires Nerio Therapeutics
May 22, 2024
Partnership for first-in-class cancer and CRM treatments
February 08, 2024
Boehringer Ingelheim and CBmed join forces to translate novel cancer therapy approaches faster into new medicines for patients
November 22, 2023
Boehringer Ingelheim expands immuno-oncology portfolio with the acquisition of bacterial cancer therapy specialist T3 Pharma
January 09, 2023
New cancer therapeutics collaboration with 3T Bio
June 02, 2022
A*STAR antibodies bolster ADC and T-Cell engager development
September 21, 2021
Acquisition to advance cancer immunology research
September 16, 2021
Clinical collaboration with Amgen on KRAS
April 14, 2021
Expansion of Collaboration with MD Anderson to Explore KRAS and TRAILR2 Compounds in Lung Cancer
Media Contacts
Head of Global Media Relations
E-Mail:
harro.ten_wolde@boehringer-ingelheim.com
Phone Number:
+49 (6132) 77-181352
Senior Media Relations Manager
E-Mail:
tereza.urbankova@boehringer-ingelheim.com
Phone Number:
+49 (6132) 77-184817
Head of Human Pharma Communications
E-Mail:
anthonia.aboyeji@boehringer-ingelheim.com
Phone Number:
+49 (6132) 77-172370
Head of Animal Health Communications
E-Mail:
Heidi.DeWit-Sommerfeld@boehringer-ingelheim.com
Phone Number:
+49 (6132) 77-171799